Analysts' Upgrades, Downgrades: Chevron
Change in Ratings
Agilent
(A) - Get Report
price target raised at Goldman to $38 from $37, based on better-than-expected quarterly results and positive guidance. Note that company provided revenue and earnings guidance for two forward quarters (historically only one quarter). Maintained neutral rating.
Atwood Oceanics
(ATW)
initiated at UBS with a buy rating and $125 price target. 2008 EPS estimates introduced at $6.57.
Cellcom
(CEL) - Get Report
upgraded at Jefferies to buy from neutral. 2008 EPS estimates raised to $2.70 from $2.15. Price target raised to $40 from $33.
Chevron
(CVX) - Get Report
upgraded at UBS to buy from neutral. 2008 EPS estimates raised to $12.94 from $9.53. Price target raised to $115 from $100.
Diamond Offshore
(DO) - Get Report
initiated at UBS with a buy rating and $160 price target. 2008 EPS estimates introduced at $10.00.
Ensco International
(ESV)
initiated at UBS with a buy rating and an $85 price target. Introduces 2008 EPS estimates of $8.13.
Hercules Offshore
(HERO)
initiated at UBS with a neutral rating and $35 price target. Introduces 2008 EPS estimates of $1.46.
Longs Drug Stores
( LDG) initiated at UBS with a buy rating and $55 price target. Introduces fiscal 2009 EPS estimates of $3.07.
Noble Corporation
(NE) - Get Report
initiated at UBS with a buy rating and $81 price target. 2008 EPS estimates set at $6.06.
Price International
( PDE) initiated at UBS with a neutral rating and $49 price target. Introduces 2008 EPS estimates of $4.94.
Plains Exploration & Production
(PXP)
upgraded at UBS to buy from neutral. 2008 EPS estimates raised to $14.68 from $12.66. Price target raised to $80 from $75.
Rowan Companies
(RDC)
initiated at UBS with a buy rating and $53 price target. Introduces 2008 EPS estimates of $4.39.
Transocean
(RIG) - Get Report
initiated at UBS with a buy rating and $201 price target. Introduces 2008 EPS estimates of $15.13.
Stock Comments/EPS Changes
CGGVeritas
( CGV) numbers lowered at Jefferies. 2008 EPS estimates lowered to $3.25 from $3.52. Price target lowered to $61 from $64. Maintains buy rating.
This article was written by a staff member of TheStreet.com.